Navigation Links
Capasso lab demonstrates highly unidirectional 'whispering gallery' microlasers
Date:12/13/2010

Cambridge, Mass., December 6, 2010 Utilizing a century-old phenomenon discovered in St. Paul's Cathedral, London, applied scientists at Harvard University have demonstrated, for the first time, highly collimated unidirectional microlasers.

The result of a collaboration with researchers from Hamamatsu Photonics in Hamamatsu City, Japan, and the Institute of Theoretical Physics of the University of Magdeburg, Germany, the advance has a wide range of new applications in photonics such as sensing and communications.

Published online this week in the Proceedings of the National Academy of Sciences, the research team took advantage of a concept in physics referred to as "whispering gallery modes."

Over a century ago, British scientist Lord Rayleigh wondered how two people standing on opposite sides of the dome in St. Paul's Cathedral could hear each other by whispering into the circular wall. He discovered that the sound skirts along the smooth surface of the wall with negligible attenuation due to scattering or absorption.

The optical analog of whispers in a dome are light rays confined to the perimeter of tiny circular disks by multiple reflections from the boundary as they circle around. Because attenuation is minimal within the smooth disk, these resonators have already been used to make some of the world's lowest-threshold lasers. Circular disks, however, have posed certain challenges.

"One of the crucial unsolved problems of these microlasers for practical applications has been that their emission is non-directional and their optical power output is negligible," said team leader Federico Capasso, Robert L. Wallace Professor of Applied Physics and Vinton Hayes Senior Research Fellow in Electrical Engineering at Harvard's School of Engineering and Applied Sciences (SEAS).

"Light gets trapped by these whispering gallery modes with little chance to escape except by a faint isotropic emission. Strategies to suitably deform the disks to solve this problem have yielded disappointing results," Capasso added.

By shaping the microlaser as an ellipse with a wavelength-size notch carved out from its edge, Capasso's team found that the cycling whispering gallery modes scatter efficiently off the notch and emerge as nearly parallel beams from the microlaser.

The prototypes are quantum cascade lasers emitting an optical power of 5 milliwatts at a wavelength of 10 microns. The microlaser performance is insensitive to the details of the notch, making this device design very robust.

"Our calculations show that the notched elliptical microlaser should have even better performance at the shorter wavelengths near 1 micron, typical of laser diodes used in optical communications, where the attenuation of whispering gallery modes is negligible," said coauthor Jan Wiersig of the Institute of Theoretical Physics of the University of Magdeburg.

"The successful realization of these simple-structured and robust microlasers through standard wafer-based fabrication makes small-volume directional light sources possible for many important applications such as photonic integrated circuits with high-density chip-scale integration, optical communications, medical/biological sensors, and lab-on-a-chip," said coauthor Masamichi Yamanishi, Research Fellow of Central Research Laboratories at Hamamatsu.


'/>"/>

Contact: Caroline Perry
cperry@seas.harvard.edu
617-496-1351
Harvard University
Source:Eurekalert  

Related biology technology :

1. Laser pioneer Federico Capasso awarded Berthold Leibinger Zukunftspreis
2. Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema
3. Molecular Detections Detect-Ready™ MRSA Assay Demonstrates Strong Performance In Independent Comparative Study From Leading UK Hospital
4. Newly Published Caldolor® Clinical Data Demonstrates 77% Reduction in Fever in Hospitalized Patients
5. Data Published Today Reveal That Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients
6. New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments
7. New Study Demonstrates Clinical Validity of EarlyCDT-Lung™
8. Æterna Zentaris: Publication in the Journal of the National Cancer Institute Demonstrates Perifosine Single Agent Potential in Neuroblastoma Tumors
9. New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy
10. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
11. S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Capasso lab demonstrates highly unidirectional 'whispering gallery' microlasers
(Date:8/11/2017)... ... August 11, 2017 , ... A staple in the community ... that will incorporate important key elements including a new digital marketing strategy and updated ... supported them, Bill Miller has partnered with the South Texas Blood & Tissue Center ...
(Date:8/11/2017)... ... August 11, 2017 , ... “There is an increasing ... alternatives to synthetic ingredients,” said Matt Hundt, President of Third Wave Bioactives. “Combining ... presence and know-how of Biorigin will allow us to bring truly novel fermented ...
(Date:8/10/2017)... , ... August 09, 2017 , ... ... classroom next week-- as students. From August 14th through the 16th, the University ... which debuted in the summer of 2016, provides Philadelphia-based middle school educators an ...
(Date:8/10/2017)... ... August 09, 2017 , ... Each year in the ... recover well enough to live an independent lifestyle and, even worse, the one-year mortality ... discovery by doctors at the University of California Davis Medical Center (Sacramento) and Second ...
Breaking Biology Technology:
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/22/2017)... 21, 2017 Optimove , provider ... retailers such as 1-800-Flowers and AdoreMe, today announced ... and Replenishment. Using Optimove,s machine learning algorithms, these ... and replenishment recommendations to their customers based not ... of customer intent drawn from a complex web ...
Breaking Biology News(10 mins):